Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine
- PMID: 2848843
- DOI: 10.1016/0092-1157(88)90015-7
Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine
Abstract
A combined vaccine against varicella and measles-mumps-rubella made by mixing two commercially available products (Varilrix and Pluserix SK-RIT) has proved to be only partially successful in early trials. Although the seroconversion rates with the MMR components were comparable with those usually achieved, the varicella take was depressed to 77%. A new low dose measles-mumps-rubella vaccine was prepared in which the measles virus content was reduced to 1/5 and the mumps virus content to 1/8. Commercial varicella vaccine was added to the low dose MMR vaccine. The seroconversion rates for measles was 98.2%, for mumps 100%, for rubella 99.4% and for varicella 98%. This product seemed to be well balanced in respect of a possible interference between the four different virus vaccine strains.
Similar articles
-
Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine.J Biol Stand. 1988 Oct;16(4):269-73. doi: 10.1016/0092-1157(88)90014-5. J Biol Stand. 1988. PMID: 3198657
-
[Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].Kansenshogaku Zasshi. 1992 Jun;66(6):776-80. doi: 10.11150/kansenshogakuzasshi1970.66.776. Kansenshogaku Zasshi. 1992. PMID: 1331262 Japanese.
-
Combined vaccine against measles, mumps, rubella, and varicella.Pediatrics. 1988 Jun;81(6):779-84. Pediatrics. 1988. PMID: 2835743 Clinical Trial.
-
Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella?Scand J Soc Med. 1988;16(3):129-35. doi: 10.1177/140349488801600301. Scand J Soc Med. 1988. PMID: 3057621 Review.
-
Measles, mumps, rubella, and varicella.Lancet. 1990 Jun 9;335(8702):1384-7. doi: 10.1016/0140-6736(90)91255-9. Lancet. 1990. PMID: 1971671 Review. No abstract available.
Cited by
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407. doi: 10.1002/14651858.CD004407.pub5 PMID: 32309885 Free PMC article. Updated.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD004407. doi: 10.1002/14651858.CD004407.pub5. Cochrane Database Syst Rev. 2021. PMID: 34806766 Free PMC article. Review.
-
Well-balanced immune response and protective efficacy induced by a single dose of live attenuated tetravalent dengue vaccine (KD-382) in monkeys.Heliyon. 2020 Jul 28;6(7):e04506. doi: 10.1016/j.heliyon.2020.e04506. eCollection 2020 Jul. Heliyon. 2020. PMID: 32760828 Free PMC article.
-
Vaccines for measles, mumps and rubella in children.Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD004407. doi: 10.1002/14651858.CD004407.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2020 Apr 20;4:CD004407. doi: 10.1002/14651858.CD004407.pub4 PMID: 22336803 Free PMC article. Updated. Review.
-
A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.Hum Vaccin Immunother. 2019;15(3):549-559. doi: 10.1080/21645515.2019.1568159. Epub 2019 Feb 15. Hum Vaccin Immunother. 2019. PMID: 30689507 Free PMC article. Clinical Trial.